Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets

被引：0
|
作者：
Kozma, Chris [1 ]
Evans, Emily [2 ]
Lebson, Lori [2 ]
Phillips, Amy [2 ]
Lobo, Carroline [2 ]
机构：
[1] CK Consulting Associates LLC, Baton Rouge, LA USA
[2] EMD Serono Inc, Rockland, MA USA
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203948
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P14-3.001
引用
收藏
页数：3
相关论文
共 50 条
  • [31] HOSPITALIZATIONS AMONG BIPOLAR DISORDER PATIENTS BEFORE AND AFTER INITIATING LURASIDONE IN A COMMERCIALLY INSURED POPULATION
    Hassan, M.
    Wade, S. W.
    Meyer, N. M.
    Pikalov, A.
    Loebel, A.
    Rajagopalan, K.
    VALUE IN HEALTH, 2013, 16 (03) : A68 - A68
  • [32] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Rammohan, Kottil
    Coyle, Patricia K.
    Sylvester, Elke
    Galazka, Andrew
    Dangond, Fernando
    Grosso, Megan
    Leist, Thomas P.
    DRUGS, 2020, 80 (18) : 1901 - 1928
  • [33] MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
    Comi, Giancarlo
    Cook, Stuart D.
    Giovannoni, Gavin
    Rammohan, Kottil
    Rieckmann, Peter
    Sorensen, Per Soelberg
    Vermersch, Patrick
    Hamlett, Anthony C.
    Viglietta, Vissia
    Greenberg, Steven J.
    JOURNAL OF NEUROLOGY, 2013, 260 (04) : 1136 - 1146
  • [34] Correction to: Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis
    Victoria J. Muir
    Greg L. Plosker
    CNS Drugs, 2020, 34 : 447 - 447
  • [35] Cladribine tablets for the treatment of relapsing-remitting multiple sclerosis
    Comi, Giancarlo
    Hartung, Hans-Peter
    Kurukulasuriya, Nuwan C.
    Greenberg, Steven J.
    Scaramozza, Matthew
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (01) : 123 - 136
  • [36] MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study
    Giancarlo Comi
    Stuart D. Cook
    Gavin Giovannoni
    Kottil Rammohan
    Peter Rieckmann
    Per Soelberg Sørensen
    Patrick Vermersch
    Anthony C. Hamlett
    Vissia Viglietta
    Steven J. Greenberg
    Journal of Neurology, 2013, 260 : 1136 - 1146
  • [37] The Development of Cladribine Tablets for the Treatment of Multiple Sclerosis: A Comprehensive Review
    Kottil Rammohan
    Patricia K. Coyle
    Elke Sylvester
    Andrew Galazka
    Fernando Dangond
    Megan Grosso
    Thomas P. Leist
    Drugs, 2020, 80 : 1901 - 1928
  • [38] Reduced Grey Matter Atrophy in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets
    Battaglini, Marco
    Sormani, Maria Pia
    Luchetti, Ludovico
    Gentile, Giordano
    Cortese, Rosa
    Alexandri, Nektaria
    De Stefano, Nicola
    NEUROLOGY, 2021, 96 (15)
  • [39] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Hermann, Robert
    Karlsson, Mats O.
    Novakovic, Ana M.
    Terranova, Nadia
    Fluck, Markus
    Munafo, Alain
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 283 - 297
  • [40] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Robert Hermann
    Mats O. Karlsson
    Ana M. Novakovic
    Nadia Terranova
    Markus Fluck
    Alain Munafo
    Clinical Pharmacokinetics, 2019, 58 : 283 - 297
12345